ArticleCancer chemotherapy and pharmacology2017

Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms.

Tristan M Sissung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.